W 273 (Lamotrigine extended-release 100 mg)
Pill imprint W 273 has been identified as Lamotrigine extended-release 100 mg.
Lamotrigine is used in the treatment of bipolar disorder; anxiety; schizoaffective disorder; borderline personality disorder; seizure prevention (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- W 273
- 100 mg
- Prescription only
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Wockhardt USA LLC
- National Drug Code (NDC):
- Inactive Ingredients:
- diethyl phthalate
ferric oxide red
ferric oxide yellow
methacrylic acid - ethyl acrylate copolymer (1:1) type a
More about lamotrigine
- Lamotrigine chewable dispersible tablets
- Lamotrigine extended-release tablets
- Lamotrigine orally disintegrating tablets
- Lamotrigine (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.